HINGHAM, Mass. , Nov. 25, 2019 (GLOBE NEWSWIRE) -- Further demonstrating its commitment to expand and protect its Intellectual Property (IP) portfolio, Microbot Medical Inc. (Nasdaq: MBOT) was issued a Notice of Allowance for patent application No. 15/936,878 by the U.S.
HINGHAM, Mass. , Oct. 30, 2019 (GLOBE NEWSWIRE) -- In an expansion of its significant global patent estate, Microbot Medical Inc. (Nasdaq: MBOT) announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.
Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM ) HINGHAM, Mass. , Sept. 13, 2019 (GLOBE NEWSWIRE) -- Having successfully executed a number of significant milestones over the past twelve months, Microbot Medical Inc. (NASDAQ: MBOT) held its 2019 annual shareholders'
Positive Results Continue to Validate the Operational Effectiveness of the SCS™ HINGHAM, Mass. , Sept. 10, 2019 (GLOBE NEWSWIRE) -- Having successfully concluded an independent in-vitro laboratory study and published the positive results earlier this year, the operational effectiveness of Microbot
HINGHAM, Mass. , Sept. 05, 2019 (GLOBE NEWSWIRE) -- At the upcoming Rodman & Renshaw Global Investment Conference , Harel Gadot , CEO, President and Chairman of Microbot Medical Inc. (Nasdaq: MBOT), will demonstrate a working prototype of the Company’s Self-Cleaning Shunt (SCS™). Mr.
HINGHAM, Mass. , July 24, 2019 (GLOBE NEWSWIRE) -- As it continues to expand and diversify its Intellectual Property (IP) portfolio, Microbot Medical (Nasdaq: MBOT) announced that it has received a Notice of Allowance from the Israel Intellectual Property Office for Patent Application No .
HINGHAM, Mass. , April 23, 2019 (GLOBE NEWSWIRE) -- As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP portfolio as it receives a Notice of Allowance from the Canadian Intellectual Property Office for Patent
HINGHAM, Mass. , Jan. 23, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with institutional
HINGHAM, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) demonstrated an activated Self-Cleaning Shunt (SCS TM ) during recent one-on-one investor and analyst meetings in San Francisco, which took place during the same week as the JP Morgan Healthcare conference.
